Novai

Reading, United Kingdom

Novai is a disruptive British biotech start-up with an AI supported retinal biomarker for use in glaucoma and AMD clinical trials.

Dec 2024

Seed

Top Investors

SFC CapitalAscension Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Novai's investors?

Novai's investors include SFC Capital, Ascension Ventures.

Where is Novai headquartered?

Novai is headquartered in Reading, United Kingdom.

What does Novai do?

Novai is a disruptive British biotech start-up with an AI supported retinal biomarker for use in glaucoma and AMD clinical trials.

What stage is Novai at?

Novai is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 18, 2024.

MLA

"Novai — Funding & Investors." VCBacked, December 18, 2024, https://www.vcbacked.co/company/novai. Accessed July 1, 2026.

APA

VCBacked. (2024). Novai — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/novai

Wikipedia (cite web)

{{cite web |title=Novai — Funding & Investors |url=https://www.vcbacked.co/company/novai |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 18, 2024.